CVRx (CVRX) Piper Sandler 36th Annual Healthcare Conference summary

Leadership insights and organizational changes

• CEO observed a significant market opportunity, unique technology, and strong patient impact after joining.

• Executive team changes and new processes implemented to improve go-to-market strategy.

• Early results from new leadership are visible, with full impact expected in 3-4 quarters.

Reimbursement and regulatory updates

• Outpatient reimbursement rate successfully defended at $45,000 for a second year; inpatient reimbursement doubled to match.

• Category I code accepted, effective January 2026, expected to reduce denials and improve predictability.

• Inpatient and outpatient reimbursement parity provides business stability against regulatory changes.

Market development and commercial strategy

• Shifted focus to high-volume centers, targeting 300-400 accounts with significant patient pools.

• Sales team expansion and territory optimization underway, aiming for deeper penetration in key centers.

• Utilization per center averages eight revenue units annually, with substantial upside potential.